Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: The health, aging, and body composition study: Brief reports

Journal of the American Geriatrics Society

Volumn 57, Issue 7, 2009, Pages 1213-1218

  Hu, Donglei ^a,b   Pawlikowska, Ludmila ^a,b   Kanaya, Alka ^a   Hsueh, Wen Chi ^a,b   Colbert, Lisa ^a   Newman, Anne B ^a   Satterfield, Suzanne ^b   Rosen, Clifford ^c,d   Cummings, Steven R ^d,e   Harris, Tamara B ⁱ   Ziv, Elad ^a,f,g,h  

^a UCSF Box 1732 ^*

^b Institute for Human Genetics

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF WISCONSIN MADISON   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g ST JOSEPH HOSPITAL   (United States)

^h CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

ⁱ NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; IGF 1; IGFBP; Mortality

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C;

AGED; AGING; ARTICLE; BODY FAT; CORRELATION ANALYSIS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MALE; MORTALITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

ACTIVITIES OF DAILY LIVING; ADIPOSITY; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY COMPOSITION; CHI-SQUARE DISTRIBUTION; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; MALE; MORTALITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; UNITED STATES;

EID: 67649743588     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2009.02318.x     Document Type: Article

References (28)

1. Yakar S, Kim H, Zhao H et al. The growth hormone-insulin like growth factor axis revisited: Lessons from IGF-1 and IGF-1 receptor gene targeting. Pediatr Nephrol 2005 20 : 251 254. (Pubitemid 40309926)
2. Pavelić JMT, Knežević J. Biological & physiological aspects of action of insulin-like growth factor peptide family. Indian J Med Res 2007 125 : 511 522. (Pubitemid 47099107)
3. Guarente L, Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000 408 : 255 262. (Pubitemid 30839431)
4. Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003 299 : 1346 1351. (Pubitemid 36254639)
5. Holzenberger M, Dupont J, Ducos B et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003 421 : 182 186.
6. Russo V, Gluckman P, Feldman E et al. The Insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Rev 2005 26 : 916 943. (Pubitemid 41770158)
7. Ahmed RL, Thomas W, Schmitz KH. Interactions between insulin, body fat, and insulin-like growth factor axis proteins. Cancer Epidemiol Biomarkers Prev 2007 16 : 593 597. (Pubitemid 46548665)
8. Rajpathak SN, McGinn AP, Strickler HD et al. Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Horm IGF Res 2008 18 : 166 173. (Pubitemid 351292519)
9. Sandhu M, Heald A, Gibson J et al. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: A prospective observational study. Lancet 2002 359 : 1740 1745. (Pubitemid 34607089)
10. Wheatcroft SB, Kearney MT, Shah AM et al. IGF-binding protein-2 protects against the development of obesity and insulin resistance. Diabetes 2007 56 : 285 294. (Pubitemid 46263063)
11. Kaplan RC, McGinn AP, Pollak MN et al. Total insulinlike growth factor 1 and insulinlike growth factor binding protein levels, functional status, and mortality in older adults. J Am Geriatr Soc 2008 56 : 652 660.
12. Saydah S, Graubard B, Ballard-Barbash R et al. Insulin-like growth factors and subsequent risk of mortality in the United States. Am J Epidemiol 2007 166 : 518 526. (Pubitemid 47283642)
13. Hornik K. The R FAQ [on-line]. Available at Accessed August 20, 2007.
14. Harrela M, Qiao Q, Koistinen R et al. High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men. Horm Metab Res 2002 34 : 144 149. (Pubitemid 34293272)
15. Wallander M, Norhammar A, Malmberg K et al. IGF binding protein 1 predicts cardiovascular morbidity and mortaligyin patients with acute myocardial infarction and type 2 diabetes. Diabetes Care 2007 30 : 2343 2348. (Pubitemid 47359045)
16. Kaplan RC, McGinn AP, Pollak MN et al. High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly. Am Heart J 2008 155 : 1006 1012.
17. Laughlin GA, Barrett-Connor E, Criqui MH et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004 89 : 114 120. (Pubitemid 38183869)
18. Nakaoka D, Sugimoto T, Kaji H et al. Determinants of bone mineral density and spinal fracture risk in postmenopausal Japanese women. Osteoporos Int 2001 12 : 548 554. (Pubitemid 32777430)
19. Amin S, Riggs BL, Atkinson EJ et al. A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res 2004 19 : 1075 1083. (Pubitemid 41110558)
20. van den Beld AW, Blum WF, Pols HA et al. Serum insulin-like growth factor binding protein-2 levels as an indicator of functional ability in elderly men. Eur J Endocrinol/Eur Federation Endocr Soc 2003 148 : 627 634. (Pubitemid 36758292)
21. Hassfeld S, Eichhorn C, Stehr K et al. Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy. Heart (British Cardiac Society) 2007 93 : 359 360. (Pubitemid 46579529)
22. Baron-Hay S, Boyle F, Ferrier A et al. Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin Cancer Res 2004 10 : 1796 1806. (Pubitemid 38435571)
23. Kelley KM, Oh Y, Gargosky SE et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochemist Cell Biol 1996 28 : 619 637. (Pubitemid 26174707)
24. Niedernhofer LJ, Garinis GA, Raams A et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature 2006 444 : 1038 1043. (Pubitemid 46018517)
25. Selman C, Lingard S, Choudhury A et al. Evidence for lifespan extension and delayed age-related biomarkers in insulin receptor substrate 1 null mice. FASEB J 2007 22.
26. Taguchi A, Wartschow L, White M. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007 317 : 369 372.
27. Clemmons D. Involvement of insulin-like growth factor-I in the control of glucose homeostasis. Curr Opin Pharmacol 2006 6 : 620 625. (Pubitemid 44752640)
28. Nedelec B, De Oliveira A, Garrel D. Acute phase modulation of systemic insulin-like growth factor-1 and its binding proteins after major burn injuries. Crit Care Med 2003 31 : 1794 1801. (Pubitemid 36714239)